Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.

Results after an average follow-up of 3 years are presented on 485 patients in the 3rd MRC therapeutic trial in myelomatosis. The 353 non-azotaemic patients (199 now dead) were randomized between i.v. cyclophosphamide (CY) and oral melphalan with prednisone (M & P). THose treated with M & P...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1980
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010576/
https://www.ncbi.nlm.nih.gov/pubmed/7006664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010576/
https://www.ncbi.nlm.nih.gov/pubmed/7006664

Ejemplares similares